Hamilton James C
Chief Medical Officer at ARWR
- Sold, on record
- $14.4M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Apr 23, 2026
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARWRARROWHEAD PHARMACEUTICALS, INC.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARWRRoutineSep 2, 2025 2025
Sold 15,000 shares at $25.00 ($375k)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 5.7% of holdings ($6.6M position)247,122 shares left1.5x usual sizeFollows a Form 144Filing
- 2 Form 144 notice ARWRNoticeSep 12, 2025 +10 days
Filed to sell 15,000 shares ($450k)
Hamilton James C, Officer
10b5-1 plan1.2x usual sizeFiling
- 3 Form 4 sale ARWRRoutineSep 12, 2025 same day
Sold 15,000 shares at $30.00 ($450k)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 6.1% of holdings ($7.4M position)232,122 shares left1.2x usual sizeFollows a Form 144Filing
- 4 Form 144 notice ARWRNoticeOct 1, 2025 +19 days
Filed to sell 20,000 shares ($700k)
Hamilton James C, Officer
10b5-1 plan1.3x usual sizeFiling
- 5 Form 4 sale ARWRRoutineOct 1, 2025 same day
Sold 20,000 shares at $35.00 ($700k)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 8.6% of holdings ($8.1M position)212,122 shares left1.3x usual sizeFollows a Form 144Filing
- 6 Form 4 sale ARWRRoutineJan 5, 2026 +96 days
Sold 40,164 shares at $63.11 ($2.5M)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 18.9% of holdings ($13.4M position)171,958 shares left2.7x usual sizeFiling
- 7 Form 4 sale ARWRRoutineMar 5, 2026 +59 days
Sold 10,000 shares at $64.19 ($642k)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 4% of holdings ($15.9M position)236,958 shares left0.7x usual sizeFiling
- 8 Form 4 sale ARWRRoutineApr 23, 2026 +49 days
Sold 10,000 shares at $75.00 ($750k)
Hamilton James C, Chief Medical Officer
10b5-1 planSold 4.2% of holdings ($17.8M position)226,958 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (29)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 24, 2026 | ARWR | Chief Medical Officer | Form 4 sale | 10,000 | $750k | 4.2% | Routine | SEC |
| Mar 5, 2026 | Mar 9, 2026 | ARWR | Chief Medical Officer | Form 4 sale | 10,000 | $642k | 4.0% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | ARWR | Chief Medical Officer | Form 4 sale | 40,164 | $2.5M | 18.9% | Routine | SEC |
| Oct 1, 2025 | Oct 3, 2025 | ARWR | Chief Medical Officer | Form 4 sale | 20,000 | $700k | 8.6% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | ARWR | Officer | Form 144 notice | 20,000 | $700k | Notice | SEC | |
| Sep 12, 2025 | Sep 16, 2025 | ARWR | Chief Medical Officer | Form 4 sale | 15,000 | $450k | 6.1% | Routine | SEC |
| Sep 12, 2025 | Sep 12, 2025 | ARWR | Officer | Form 144 notice | 15,000 | $450k | Notice | SEC | |
| Sep 2, 2025 | Sep 4, 2025 | ARWR | Chief Medical Officer | Form 4 sale | 15,000 | $375k | 5.7% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | ARWR | Officer | Form 144 notice | 15,000 | $375k | Notice | SEC | |
| Aug 15, 2025 | Aug 15, 2025 | ARWR | Chief Medical Officer | Form 4 sale | 10,000 | $200k | 3.7% | Routine | SEC |
| Aug 15, 2025 | Aug 15, 2025 | ARWR | Officer | Form 144 notice | 9,389 | $188k | Notice | SEC | |
| Aug 13, 2025 | Aug 13, 2025 | ARWR | Officer | Form 144 notice | 611 | $12k | Notice | SEC | |
| Jan 6, 2025 | Jan 7, 2025 | ARWR | Chief Discovery/Trans Medicine | Form 4 sale | 32,729 | $649k | 10.7% | Unusual | SEC |
| Jan 6, 2025 | Jan 6, 2025 | ARWR | Officer | Form 144 notice | 32,729 | $649k | Notice | SEC | |
| Apr 1, 2024 | Apr 3, 2024 | ARWR | Chief Discovery/Trans Medicine | Form 4 sale | 6,000 | $168k | 2.8% | No plan | SEC |
| Apr 1, 2024 | Apr 1, 2024 | ARWR | Officer | Form 144 notice | 6,000 | $168k | Notice | SEC | |
| Jan 12, 2024 | Jan 17, 2024 | ARWR | Chief Discovery/Trans Medicine | Form 4 sale | 7,940 | $293k | 3.6% | Routine | SEC |
| Jan 12, 2024 | Jan 12, 2024 | ARWR | Officer | Form 144 notice | 7,940 | $287k | Notice | SEC | |
| Jan 5, 2024 | Jan 5, 2024 | ARWR | Officer | Form 144 notice | 10,000 | $350k | Notice | SEC | |
| Jan 5, 2024 | Jan 5, 2024 | ARWR | Officer | Form 144 notice | 22,143 | $781k | Notice | SEC | |
| Jan 5, 2024 | Jan 5, 2024 | ARWR | Other | Form 4 sale | 38,443 | $1.3M | 14.9% | Unusual | SEC |
| Jan 4, 2024 | Jan 4, 2024 | ARWR | Officer | Form 144 notice | 6,300 | $203k | Notice | SEC | |
| Jun 30, 2023 | Jul 5, 2023 | ARWR | Other | Form 4 sale | 3,000 | $107k | 1.6% | No plan | SEC |
| Jun 30, 2023 | Jun 30, 2023 | ARWR | Officer | Form 144 notice | 3,000 | $107k | Notice | SEC | |
| Jan 5, 2023 | Jan 6, 2023 | ARWR | Other | Form 4 sale | 13,803 | $516k | 6.7% | Plan not stated | SEC |
| Jan 3, 2023 | Jan 5, 2023 | ARWR | Other | Form 4 sale | 10,338 | $397k | 6.6% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 6, 2022 | ARWR | Other | Form 4 sale | 25,625 | $1.7M | 14.1% | Plan not stated | SEC |
| Jan 14, 2021 | Jan 15, 2021 | ARWR | Other | Form 4 sale | 10,000 | $813k | 7.3% | Plan not stated | SEC |
| Jan 6, 2021 | Jan 7, 2021 | ARWR | Other | Form 4 sale | 38,750 | $2.8M | 22.1% | Plan not stated | SEC |